This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Morgan Stanley's MSSB Acquisition A 'Game Changer': UBS

Morgan Stanley (MS - Get Report) pulls ahead of Goldman Sachs Group Inc (GS - Get Report) in USB AG (UBS)'s recent research on US brokers and asset managers by analysts Brennan Hawken and David Eads.

"Morgan Stanley (MS - Get Report) shares have outperformed Goldman Sachs Group Inc (GS - Get Report) by 8.8% since early September MS is up 14.2% and GS is up 5.4% and we expect this outperformance to continue. Specifically, we see several factors driving strong relative performance for MS, including: 1 a better positioned securities business in the current environment, 2 less downside from a harsh Volcker rule, 3 a business mix that tends to garner a higher multiple, and 4 consensus estimates that seem too low to us," say the UBS analysts.

Morgan stanley performance

What's working for Morgan Stanley

According to UBS, Morgan Stanley's realignment of business priorities in favor of wealth management and a stronger equities business should yield the following advantages:

  • These businesses are comparatively less capital intensive
  • They offer scope for improving the mix in favor of more profitable businesses
  • Stable earnings and potential for high deposit funding
  • Favored by regulators for the last-mentioned reason above.

Additionally, Morgan Stanley (MS - Get Report) has scored a coup by acquiring MSSB, and this is a 'game-changer' say USB AG (UBS), leading to a re-rating of the stock.

2-better-earnings Morgan stanley

Goldman Sachs relying on expense control

On the other hand Goldman Sachs Group Inc (GS - Get Report) has reported profitability that relied more on expense reduction compared to revenue generation. "We believe it is unlikely that Goldman Sachs will be able to drive meaningfully higher returns without an improvement in the revenue outlook. Further, as long as double-digit returns are delivered through expense control, we expect the multiple on Goldman Sachs shares should remain constrained," say the analysts.

Market under-estimating Morgan Stanley

UBS AG (UBS)'s earnings projections for Morgan Stanley (MS - Get Report), which recently incorporated interest income arising from the wealth management business, indicate that its earnings growth is likely to be far superior to that of Goldman Sachs Group Inc (GS - Get Report).

According to UBS, the consensus earnings estimates for Morgan Stanley are unduly lower than warranted: "Our 2014 and 2015 estimates are meaningfully above consensus, and we see considerable upside to our numbers due to the potential for strong loan growth and upside from rising rates."

In addition, the market is not factoring the proper size of the buyback that regulators would allow Morgan Stanley (MS - Get Report) - in UBS AG UBS's view this could be as high as $3B.

Morgan Stanley's IB business more sheltered from regulators

UBS analysts are of the opinion that the shrinkage of FICC business at Morgan Stanley (MS - Get Report), which in any case was a drag on IB earnings, would also relieve regulatory pressure/scrutiny. "We have been encouraged by the steady shrinking of their FICC RWAs. Therefore, even if MS is not able to generate returns above its cost of capital in FICC, the declining prominence of this business should improve the firm's return profile in the IB."

On the other hand, the company's huge scale in Equities would shield it from increasing competition in this area, as well as allow it to generate excellent returns on the regulatory capital invested in this business.

3-better-am-earnings Morgan stanley


4-ratings Morgan stanley

UBS AG (UBS) have a price target of $37 on Morgan Stanley (MS - Get Report) on the basis of 11X their 2015 EPS in 12 months.

-By Saul Griffith

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GS $160.07 -1.88%
MS $26.28 -2.27%
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs